Patient characteristics
Patients . | Days to first positive PCR . | Maximum viral load, copies/mL . | Duration of infection, duration of positive PCR in days . | Days to CD4 from first positive PCR . | Days to CD8 from first positive PCR . | First antibody appearance, days from first positive PCR . | Clinical symptoms . | Start of antiviral therapy, days from transplantation . | Rejection episodes, number, days from transplantation . | Rejection therapy . |
---|---|---|---|---|---|---|---|---|---|---|
Asymptomatic patients | ||||||||||
1 | 26 | 22 000 | 28 | 10 | 21 | 14 | NA | NA | 0 | NA |
2 | 46 | 14 000 | 59 | 17 | 31 | 31 | NA | NA | 1, d 9 | MPNS |
3 | 18 | 22 000 | 42 | 14 | 28 | 21 | NA | NA | 0 | NA |
4 | 27 | 133 000 | 48 | 0 | 10 | 7 | NA | NA | 0 | NA |
5 | 26 | 32 000 | 66 | 10 | 24 | 17 | NA | NA | 1, d 19 | MPNS |
Median | 26 | 22 000 | 48 | 10* | 24 | 17 | NA | NA | NA | NA |
Symptomatic patients | ||||||||||
6 | 26 | 92 000 | 88 | 28 | 18 | 16 | Gastrointestinal | 33 | 0 | NA |
7 | 28 | 140 000 | 50 | 35 | 24 | 28 | Gastrointestinal | 49 | 2, d 57, 69 | MPNS, OKT 3 |
8 | 28 | 124 000 | 74 | 53 | 32 | 4 | Pancytopenia | 49 | 1, d 27 | MPNS |
9 | 22 | 140 000 | 35 | 42 | 14 | 14 | Gastrointestinal | 39 | 1, d 45 | MPNS |
Median | 27 | 132 000 | 62 | 39* | 21 | 15 | NA | 44 | NA | NA |
Patients . | Days to first positive PCR . | Maximum viral load, copies/mL . | Duration of infection, duration of positive PCR in days . | Days to CD4 from first positive PCR . | Days to CD8 from first positive PCR . | First antibody appearance, days from first positive PCR . | Clinical symptoms . | Start of antiviral therapy, days from transplantation . | Rejection episodes, number, days from transplantation . | Rejection therapy . |
---|---|---|---|---|---|---|---|---|---|---|
Asymptomatic patients | ||||||||||
1 | 26 | 22 000 | 28 | 10 | 21 | 14 | NA | NA | 0 | NA |
2 | 46 | 14 000 | 59 | 17 | 31 | 31 | NA | NA | 1, d 9 | MPNS |
3 | 18 | 22 000 | 42 | 14 | 28 | 21 | NA | NA | 0 | NA |
4 | 27 | 133 000 | 48 | 0 | 10 | 7 | NA | NA | 0 | NA |
5 | 26 | 32 000 | 66 | 10 | 24 | 17 | NA | NA | 1, d 19 | MPNS |
Median | 26 | 22 000 | 48 | 10* | 24 | 17 | NA | NA | NA | NA |
Symptomatic patients | ||||||||||
6 | 26 | 92 000 | 88 | 28 | 18 | 16 | Gastrointestinal | 33 | 0 | NA |
7 | 28 | 140 000 | 50 | 35 | 24 | 28 | Gastrointestinal | 49 | 2, d 57, 69 | MPNS, OKT 3 |
8 | 28 | 124 000 | 74 | 53 | 32 | 4 | Pancytopenia | 49 | 1, d 27 | MPNS |
9 | 22 | 140 000 | 35 | 42 | 14 | 14 | Gastrointestinal | 39 | 1, d 45 | MPNS |
Median | 27 | 132 000 | 62 | 39* | 21 | 15 | NA | 44 | NA | NA |
NA indicates not applicable; MPNS, methylprednisolone.
Statistically significant, P < .05